Hundreds of people in the United Kingdom will receive an experimental COVID-19 vaccine in what scientists say is an early trial after the drug was successfully put through a smaller early trial without any safety problems.
Shattock, who is leading the research on the vaccine at Imperial, said that "We are still doing research on it".
Russian Federation expects to start mass anti-coronavirus vaccinations, across the country, by October, the country's health minister has said.
Russian Federation is racing to be the first nation in the world to approve a COVID vaccine by mid-August. He also stressed that the five countries are planning to make Russian a vaccine against coronavirus. He said, "We're looking very carefully at the pandemic, at the numbers where the hot spots are and talking to collaborators that have the facilities to do these kinds of studies".
Out of seven prototypes tested in the study, it found that Ad26-S.PP had the highest levels of neutralising antibodies to fight infection.
Major League Baseball teams now required to have coronavirus compliance officers
The person spoke to The Associated Press on condition of anonymity Wednesday because the test results were not announced. The hope, weather permitting, was for the Jupiter site to resume practicing this weekend.
J&J's vaccine uses a common cold virus known as adenovirus type 26 or Ad26 to ferry coronavirus proteins into cells in the body, causing the body to mount an immune defense against the virus. In addition, the Health Ministry expects that developers of two more vaccines will request permission to start clinical trials on volunteers in the next six to eight weeks, added TASS.
That has not stopped Russian officials from heralding their claims, telling CNN they are aiming for August 10 or earlier, and frontline workers will get the first doses.
Human clinical trial of indigenously developed Covaxin, a possible vaccine against coronavirus, began at a hospital in Uttar Pradesh, officials said.
The World Health Organization has said multiple vaccine approaches are necessary for COVID-19, noting that the usual success rate for vaccine development is about 10 per cent. Health officials were more cautious by saying that the trials are still underway and the state registration process is expected to start after August 3.
"I'm just going to hold my breath and wait to see", he said.